Structure-based screen identifies a potent small molecule inhibitor of Stat5a/b with therapeutic potential for prostate cancer and chronic myeloid leukemia

  • Zhiyong Liao
  • , Lei Gu
  • , Jenny Vergalli
  • , Samanta A. Mariani
  • , Marco De Dominici
  • , Ravi K. Lokareddy
  • , Ayush Dagvadorj
  • , Puranik Purushottamachar
  • , Peter A. McCue
  • , Edouard Trabulsi
  • , Costas D. Lallas
  • , Shilpa Gupta
  • , Elyse Ellsworth
  • , Shauna Blackmon
  • , Adam Ertel
  • , Paolo Fortina
  • , Benjamin Leiby
  • , Guanjun Xia
  • , Hallgeir Rui
  • , David T. Hoang
  • Leonard G. Gomella, Gino Cingolani, Vincent Njar, Nagarajan Pattabiraman, Bruno Calabretta, Marja T. Nevalainen

Research output: Contribution to journalArticlepeer-review

49 Scopus citations

Fingerprint

Dive into the research topics of 'Structure-based screen identifies a potent small molecule inhibitor of Stat5a/b with therapeutic potential for prostate cancer and chronic myeloid leukemia'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science